Education & EPPS Programs
Monday, November 11, 2019
CBD's Role in Tomorrow's Pharmacy
2:00 PM - 3:00 PM
The CBD boom of 2019 has crossed all channels, including pharmacies. With unique opportunities across the board, both pharmacists and CBD brands need to understand market dynamics, consumer perceptions, product preference and the regulatory landscape in order to properly educate consumers on their health & wellness.
Bethany Gomez, Managing Director
Brightfield Group
Hemp in Retail: Evolving Federal & State Regulatory Landscapes
3:00 PM - 4:00 PM
With the passage of the 2018 Farm Bill, many expected overnight change to federal and state regulation concerning hemp and hemp products. Yet, months later, the transition and evolution of FDA regulation and state regulation continues. Federal agencies have held hearings in 2019, and many states either passed laws in 2019 or are anticipated to do so in early 2020, but hemp products remain in high demand now. So, where do retailers, brands and consumers go from here?

Join this discussion on the recent history of hemp regulation, where we are today and what should be expected in the coming months and years -- from FDA warning letters, to differentiating product types (ingestibles, cosmetics and more) to product labeling and compliance.
Garrett Graff, Esq. - Managing Attorney
Hoban Law Group
Precision Dosing of Cannabinoids: Knowns & Unknowns
4:00 PM - 5:00 PM
Recent developments with regard to medicinal and recreational marijuana legislation in the United States has led to a significant increase in self medication with cannabis. However, due to the position of the federal government, severe restrictions on research remain in place. Thus, important details remain undiscovered, which presents substantial barriers for clinicians, pharmacists and patients. As a result, there is an excess of anecdotal and misinformation regarding appropriate dosing, indications to be treated, most effective route of administration, etc.

This presentation will cover many aspects of medicinal cannabinoids based on what is currently known from the most recent scientific research literature. In addition to the challenges associated with cannabinoid therapy, the associated bioavailability of different routes of administration ranging from inhalation to transdermal, and appropriate dosing will be discussed. The unique role of the Endocannabinoid system in human pathophysiology as well as the general pharmacology of cannabinoids will also be covered. Specific indications that show promise for cannabinoid based therapies and current cannabinoid based pharmaceuticals and their approved indications will also be described. Finally, what is known and what is unknown regarding cannabinoid therapies will be summarized and the future of cannabinoids as medicine will be discussed.
Jeremy Riggle, Ph.D., Chief Scientist
Mary's Nutritionals
Call For Speaker
Elevate your industry standing when you participate in ECRM's powerful programs.
Presentations - Panel Discussions - Round Tables

For more information, contact Rachel Mayfield at 440-528-3603
;